| Sponsor Name |
PI Last Name |
PI First Name |
Title |
Start Date |
End Date |
Type |
| NIH-NIAMS |
Boes |
Marianne |
Analysis of Class II MHC and CD1d Antigen Presentation Pathways in Skin-Derived D |
3/1/2007 |
2/28/2012 |
Grant |
| |
|
|
|
|
|
|
| NIH-NIAID |
Campbell |
James |
The Role of CCR4 in Skin Lymphocyte Homing and Immunity |
7/1/2006 |
11/30/2010 |
Grant |
| |
|
|
|
|
|
|
| LEUKEMIA & LYMPHOMA SOCIETY |
Clark |
Rachael |
Generation of human autologous self-tolerant T cells using skin cells to replicate the thymus macroenvironment |
10/1/2005 |
9/30/2008 |
Grant |
| SCLERODERMA FOUNDATION |
Clark |
Rachael |
Regularory T cells in Tight Skin 2 Mouse Model of Scleroderma |
7/1/2007 |
6/30/2010 |
Grant |
| NIH-NIAID |
Clark |
Rachael |
T Cell Production from a Skin Derived Thymus Construct |
2/1/2006 |
11/30/2009 |
Grant |
| |
|
|
|
|
|
|
| NIH-NCI NATIONAL CANCER INSTITUTE |
Dimitroff |
Charles |
Analysis of Homing Receptors in Prostate Cancer |
4/5/2007 |
1/31/2012 |
Grant |
| AMERICAN CANCER SOCIETY |
Dimitroff |
Charles |
Role of Selectins in Bone Metastasis of Prostate Cancer |
1/1/2006 |
12/31/2009 |
Grant |
| |
|
|
|
|
|
|
| NIH-NIAID |
Fuhlbrigge |
Robert |
Structure Function Analysis of T Cell E-Selectin Ligands |
9/15/2003 |
12/31/2007 |
Grant |
| CHILDREN'S HOSPITAL OF BOSTON |
Fuhlbrigge |
Robert |
T Cell Modulation of Vaccinia in Normal and Atopic Human Skin: Use of Human Skin/Immune Deficient Mouse Chimeras to Model Human Disease (Project 5) |
3/31/2004 |
3/30/2009 |
Subc |
| |
|
|
|
|
|
|
| NEOSTRATA COMPANY INC. |
Kimball |
Alexandra |
"A Randomized, Single Blind, Active Control Trial Comparing the Relative Efficacy, Safety and Patient Acceptance of a Novel Coal Tar Solution + Topical Emollient ("NeoCT") vs. Calcipotriol Cream (50 m |
5/9/2006 |
5/8/2007 |
Trial |
| CENTOCOR INC. |
Kimball |
Alexandra |
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of CNTO 1275 in the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis |
4/1/2006 |
4/1/2012 |
Trial |
| PATH SCIENTIFIC LLC |
Kimball |
Alexandra |
A Randomized, Double-Blind, Placebo-Controlled, Pilot Study of 1% Terbinafine Cream Applied Twice Daily and Delivered via Nail Plate Microproation for the Treatment of Subungual Toenail Onychomycosis |
2/15/2006 |
2/14/2007 |
Trial |
| BRIGHAM AND WOMEN'S HOSPITAL |
Kimball |
Alexandra |
Partners Dermatology Joint Clinical Trial Program - Administrative Core (BWH) |
10/1/2004 |
9/30/2008 |
Misc |
| KERADERM |
Kimball |
Alexandra |
UV-C Phototherapy of Onychomycosis |
5/2/2006 |
5/1/2007 |
Trial |
| |
|
|
|
|
|
|
| NIH-NIAMS |
Kupper |
Thomas |
Dermatology Training Grant |
5/1/2006 |
4/30/2011 |
Grant |
| NIH-NIAID |
Kupper |
Thomas |
IMMUNOPHYSIOLOGY OF KERATINOCYTE CYTOKINES |
2/1/2003 |
1/31/2008 |
Grant |
| CHILDREN'S HOSPITAL OF BO |
Kupper |
Thomas |
Mouse Models of Epidermal Cytokines in the Development of Atopic Dermatitis and Response to Vaccinia (Project 9) |
3/31/2004 |
3/30/2009 |
Subc |
| DANA FARBER CANCER INSTIT |
Kupper |
Thomas |
ORTHOPOX IMMUNIZATION IN NORMALS AND PATIENTS WITH CANCER |
9/30/2003 |
3/31/2008 |
Subc |
| DANA FARBER CANCER INSTIT |
Kupper |
Thomas |
ORTHOPOX IMMUNIZATION IN NORMALS AND PATIENTS WITH CANCER |
9/30/2003 |
3/31/2008 |
Subc |
| NIH-NIAMS |
Kupper |
Thomas |
Skin Disease Research Center - Admin Core |
7/15/2004 |
3/31/2009 |
Grant |
| NIH-NIAID |
Kupper |
Thomas |
SKIN HOMING T CELLS: MOLECULAR CHARACTERIZATION OF CLA |
9/1/2002 |
2/28/2008 |
Grant |
| NIH-NCI NATIONAL CANCER I |
Kupper |
Thomas |
SPORE IN SKIN CANCER: A Genome-Wide Approach to Melanoma Classification |
9/30/2001 |
8/31/2007 |
Grant |
| |
|
|
|
|
|
|
| HARVARD MEDICAL SCHOOL |
Liu |
Luzheng |
NERCE:Distinct Priming Signals for T Cells Effector/Memory Differentiation Following Cutaneous Vaccination |
2/15/2006 |
2/14/2008 |
Subc |
| |
|
|
|
|
|
|
| BIOGEN IDEC INC. |
Qureshi |
Abrar |
ATLAS (Assessment and Tracking of Long-term Alefacept Safety). Alefacept (LFA-3/IgG1 Fusion Protein) |
8/5/2005 |
8/4/2008 |
Trial |
| NIH-NCI NATIONAL CANCER I |
Qureshi |
Abrar |
POPULATION-BASED APPROACH TO SKIN CANCER EPIDEMIOLOGY |
6/1/2006 |
5/31/2011 |
Grant |
| GENENTECH INC. |
Qureshi |
Abrar |
Raptiva RESPONSE Registry (ACD3101g)- Raptiva Epidemiologic Study of Psoriasis Outcomes and Safety Events in Patients with Chronic Moderate to Severe Plaque Psoriasis |
10/25/2005 |
10/24/2008 |
Trial |
| AMERICAN SKIN ASSOCIATION |
Qureshi |
Abrar |
Willingness-to- Pay (WTP) Stated Preferences for Eight Health -Related Quality of Life Domains in Psoriasis and Psoriatic Arhritis |
1/1/2007 |
12/31/2007 |
Grant |
| |
|
|
|
|
|
|
| NIH-NIDCR |
Rheinwald |
James |
Senescence Bypass in Epithelial Neoplastic Progression |
7/1/2005 |
6/30/2009 |
Grant |
| |
|
|
|
|
|
|
| NIH-NHLBI NATIONAL HEART |
Sackstein |
Robert |
ANALYSIS OF HOMING RECEPTORS ON HUMAN ADULT STEM CELLS |
7/1/2003 |
6/30/2007 |
Grant |
| DANA FARBER CANCER INSTITUTE |
Sackstein |
Robert |
MECHANISMS OF GRAFT VS HOST DISEASE |
4/1/2003 |
3/31/2008 |
Subc |
| HARVARD MEDICAL SCHOOL |
Sackstein |
Robert |
MINORITY K-12 INITIATIVE FOR TEACHERS AND STUDENTS (MKITS) |
9/22/2003 |
8/31/2008 |
Subc |
| NIH-NCI NATIONAL CANCER INSTITUTE |
Sackstein |
Robert |
Molecular Analysis of CD44 on Colon Cancer Cells |
7/1/2007 |
6/30/2012 |
Grant |
| MISCELLANEOUS |
Sackstein |
Robert |
SACKSTEIN DISCRETIONARY ACCOUNT |
4/1/2000 |
3/31/2009 |
Gift |
| NIH-NHLBI NATIONAL HEART |
Sackstein |
Robert |
STRUCTURE AND BIOLOGY OF HEMATOPOIETIC E-/L-SELECTIN LIGAND |
9/22/1997 |
8/31/2007 |
Grant |
| |
|
|
|
|
|
|
| CROHN'S AND COLITIS FOUNDATION |
Wurbel |
Marc |
CCR9 and CCL25 in the Gut - Specific T Lymphocytes Homing |
7/1/2006 |
6/30/2008 |
Grant |
Send Feedback to: 
